All In Biotech

Drug Trial Radar · NCT03283878

Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial

Perioperative Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty: A Prospective, Randomized, Open-label, Controlled Multi-center Trial

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,770 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,770

Actual

Start

Oct 24, 2017

Primary completion

Nov 20, 2024

Study completion Aug 22, 2025

Sponsor

Lead sponsor
Duke UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
American Association of Hip and Knee Surgeons; Orthopedic Research and Education Foundation
First posted
Sep 14, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty (TKA): Multi-Center Trial is a study that will compare the effectiveness of various perioperative strategies for antibiotic delivery as prophylaxis for periprosthetic joint infections (PJI) and surgical site infection in elective primary TKA. The investigators hypothesize that a single dose of prophylactic antibiotic administered within 60 minutes before the incision is not an effective way to prevent PJI in elective primary total knee arthroplasty (TKA). The investigators also hypothesize that the prolonged delivery (24 hours) of antibiotic prophylaxis after surgery does not further reduce the incidence of PJI in elective primary TKA. Duke University is the only site recruiting both primary total knee arthroplasty and unilateral knee arthroplasty.

Conditions

  • Arthropathy of Knee
  • Antibiotic Prophylaxis

Interventions

  • CefazolinDrug

    Cefazolin will be administered intravenously within less than 60 minutes prior to skin incision in elective TKA for Group 1. Cefazolin will be administered intravenously within less than 60 minutes prior to skin incision in elective TKA. In addition, two weight based doses of cefazolin will be administered within 24 hours postoperatively for Group 2.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Periprosthetic Infection (PJI) as Measured by Chart ReviewTime frame: up to 90 days post-operative

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • University of California, San Francisco

    San Francisco, California

  • Emory University

    Atlanta, Georgia

  • University of Maryland St. Joseph Medical Center & Orthopedic Associates

    Towson, Maryland

  • University Of Mississippi Medical Center

    Jackson, Mississippi

  • Mississippi Bone and Joint Clinic

    Starkville, Mississippi

  • University Orthopaedic Associates, LLC

    Somerset, New Jersey

  • NYU School of Medicine

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Ohio State University

    Columbus, Ohio

  • Rothman Institute

    Philadelphia, Pennsylvania

  • University of South Carolina

    Columbia, South Carolina

  • BaylorScott&White Research Institute

    Temple, Texas

  • Augusta Health

    Fishersville, Virginia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.